Sun Pharmaceutical

sunpharma.com.my

Sun is a pharmaceutical distribution company based in Malaysia. List of products in heart, skin, pain management products and our nuclear medicine product line: Bio-Quinone Q10 Bio-Quinone Q10 GOLD Bio-Marine Plus Evelle Acustop Cataplasma Kenhancer Plaster Ginsana Gincosan

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

HOLD SUN PHARMACEUTICAL, SAYS RAJAT BOSE

Pharmaceutical | January 05, 2017

news image

Rajat Bose of rajatkbose.com told CNBC-TV18, "One should hold Sun Pharmaceutical Industries with a stoploss below Rs 550 and if it falls below Rs 600 then I would advocate further buying. For fresh buy one would buy at lower levels and put a strict stoploss below Rs 550. My sense is that its downtrend has been arrested but there is not quite a reversal yet. However, this would be the best time for a long term investor to buy more. So, I would suggest buy below Rs 600 if one is willing then bu...

Read More

PREFER SUN PHARMACEUTICAL INDUSTRIES, SAYS VIJAY CHOPRA

Sun Pharmaceutical | April 13, 2017

news image

Vijay Chopra of enochventures.com told CNBC-TV18, "I would recommend the investor to get out of power generation companies and get into a power trading company....

Read More

CONSIDER A BULL SPREAD ON SUN PHARMA

Sun Pharmaceutical Industries | April 24, 2017

news image

Sun Pharmaceutical Industries (₹639.6) is ruling at a crucial level. The stock finds support at ₹610 and the crucial one at ₹572. A close below the latter will confirm the bearish trend....

Read More

U.S. DRUG PRICE EROSION POSES INCREASED CHALLENGE FOR SUN PHARMA

Sun Pharmaceutical Industries Ltd | May 26, 2017

news image

Sun Pharmaceutical Industries Ltd., India’s largest drugmaker, faces mounting pressure to resolve regulatory issues at one of its biggest factories to help offset sharply deteriorating generic drug prices in the U.S....

Read More
news image

HOLD SUN PHARMACEUTICAL, SAYS RAJAT BOSE

Pharmaceutical | January 05, 2017

Rajat Bose of rajatkbose.com told CNBC-TV18, "One should hold Sun Pharmaceutical Industries with a stoploss below Rs 550 and if it falls below Rs 600 then I would advocate further buying. For fresh buy one would buy at lower levels and put a strict stoploss below Rs 550. My sense is that its downtrend has been arrested but there is not quite a reversal yet. However, this would be the best time for a long term investor to buy more. So, I would suggest buy below Rs 600 if one is willing then bu...

Read More
news image

PREFER SUN PHARMACEUTICAL INDUSTRIES, SAYS VIJAY CHOPRA

Sun Pharmaceutical | April 13, 2017

Vijay Chopra of enochventures.com told CNBC-TV18, "I would recommend the investor to get out of power generation companies and get into a power trading company....

Read More
news image

CONSIDER A BULL SPREAD ON SUN PHARMA

Sun Pharmaceutical Industries | April 24, 2017

Sun Pharmaceutical Industries (₹639.6) is ruling at a crucial level. The stock finds support at ₹610 and the crucial one at ₹572. A close below the latter will confirm the bearish trend....

Read More
news image

U.S. DRUG PRICE EROSION POSES INCREASED CHALLENGE FOR SUN PHARMA

Sun Pharmaceutical Industries Ltd | May 26, 2017

Sun Pharmaceutical Industries Ltd., India’s largest drugmaker, faces mounting pressure to resolve regulatory issues at one of its biggest factories to help offset sharply deteriorating generic drug prices in the U.S....

Read More